Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A.S. Belldegrun is active.

Publication


Featured researches published by A.S. Belldegrun.


The Journal of Urology | 2001

SOCIETY OF UROLOGIC ONCOLOGY BIOTECHNOLOGY FORUM: NEW APPROACHES AND TARGETS FOR ADVANCED PROSTATE CANCER

A.S. Belldegrun; Neil H. Bander; Seth P. Lerner; David P. Wood; Allan J. Pantuck

PURPOSEnWe provide an overview of advances in molecular based therapeutic strategies for prostate cancer and summarize the studies presented at the Society of Urologic Oncology Biotechnology Forum in 2000.nnnMATERIALS AND METHODSnThree promising new treatment strategies are presented, and a critique of the advantages and limitations of each is offered by a leading expert in the field.nnnRESULTSnTreatment results and the current state of dendritic cell based immunotherapy, monoclonal antibody therapy and anti-apoptotic treatment approaches are presented.nnnCONCLUSIONSnCurrently patients with advanced prostate carcinoma have expanded therapeutic options available in the form of molecular based phases II and III clinical trials.


Archive | 2007

Hypoxia-Inducible Factor 1A in Clear Cell Renal Cell Carcinoma

Tobias Klatte; David B. Seligson; Stephen B. Riggs; Maria K. Berkman; Mark D. Kleid; Fairooz F. Kabbinavar; Allan J. Pantuck; A.S. Belldegrun


European Urology Supplements | 2009

319 NEPHRON SPARING SURGERY (NSS) IS SUPERIOR TO RADICAL NEPHRECTOMY IN PRESERVING RENAL FUNCTION OUTCOME: IS IT TRUE EVEN WHEN EXPANDING NSS TUMOUR SIZE INDICATIONS?

Rodolphe Thuret; Pierre Bigot; K. Bensalah; A. De La Taille; L. Salomon; C.C. Abbou; J. Tostain; L. Bellec; M. Soulié; P. Rischmann; Jean-Christophe Bernhard; Jean-Marie Ferriere; C. Pfister; Baptiste Albouy; M. Colombel; L. Zini; A. Villers; J. Rigaud; Olivier Bouchot; F. Montorsi; Roberto Bertini; A.S. Belldegrun; A.J. Pantuck; J.J. Patard


European Urology Supplements | 2008

PAPILLARY RENAL CELL CARCINOMA WITH CLEAR CELLS – PATHOLOGICAL, IMMUNOHISTOCHEMICAL AND CYTOGENETIC CHARACTERISTICS OF A NOVEL ENTITY

Tobias Klatte; Jonathan W. Said; David Seligson; M. De Martino; Jeffrey LaRochelle; Brian Shuch; Fairooz F. Kabbinavar; A.S. Belldegrun; A.J. Pantuck


European Urology Supplements | 2008

PREDICTIVE FACTORS FOR LOCAL RECURRENCE AFTER NEPHRON SPARING SURGERY IN RENAL CELL CARCINOMA

Jean-Christophe Bernhard; Jean-Marie Ferriere; A.J. Pantuck; G. Robert; Maxime Crepel; Hervé Wallerand; L. Bellec; G. Pasticier; J. Lam; M. Soulié; Baptiste Albouy; D. Lopes; Bertrand Lacroix; K. Bensalah; C. Pfister; F. Guille; J. Tostain; A. De La Taille; L. Salomon; C.C. Abbou; M. Colombel; A.S. Belldegrun; J.J. Patard


Advanced Therapeutics | 2018

Artificial Intelligence: Modulating BET Bromodomain Inhibitor ZEN-3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform (Adv. Therap. 6/2018)

Allan J. Pantuck; Dong-Keun Lee; Theodore Kee; Peter Wang; Sanjay Lakhotia; Michael H. Silverman; Colleen Mathis; Alexandra Drakaki; A.S. Belldegrun; Chih-Ming Ho; Dean Ho


Journal of Clinical Oncology | 2016

A nomogram predicting disease-specific survival after nephrectomy for papillary renal cell carcinoma

Tobias Klatte; Mesut Remzi; Jonathan W. Said; Andrea Haitel; Fairooz F. Kabbinavar; Matthias Waldert; M. de Martino; M. Marberger; A.S. Belldegrun; A.J. Pantuck


/data/revues/00904295/v58i6/S0090429501014224/ | 2011

Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template—technique and preliminary results

Amnon Zisman; Allan J. Pantuck; Jeffery K. Cohen; A.S. Belldegrun


Archive | 2010

Oncology: Adrenal/Renal/Upper Tract/Bladder Fuhrman Grade Provides Higher Prognostic Accuracy Than Nucleolar Grade for Papillary Renal Cell Carcinoma

Tobias Klatte; Christine Anterasian; Jonathan W. Said; Michela de Martino; Fairooz F. Kabbinavar; A.S. Belldegrun; Allan J. Pantuck


European Urology Supplements | 2010

418 NEW PROGNOSTIC STRATIFICATION SYSTEM IN LOCALLY ADVANCED RENAL CELL CARCINOMA PATIENTS WHO ARE CANDIDATES FOR ADJUVANT TREATMENT

Jean-Christophe Bernhard; Alain Ravaud; A.J. Pantuck; Maxime Crepel; G. Verhoest; K. Bensalah; L. Cindolo; A. De La Taille; Jean-Marie Ferriere; L. Salomon; J. Tostain; V. Ficara; G. Novara; L. Zini; A. Villers; A.S. Belldegrun; J.J. Patard

Collaboration


Dive into the A.S. Belldegrun's collaboration.

Top Co-Authors

Avatar

A.J. Pantuck

University of California

View shared research outputs
Top Co-Authors

Avatar

Tobias Klatte

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J.J. Patard

University of California

View shared research outputs
Top Co-Authors

Avatar

J. Tostain

Jean Monnet University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge